How the body processes it.
Certain variants may be related to the speed at which a medicine is transformed or eliminated.
NeoFarma Neurology
Some differences in DNA can influence how the body processes or responds to certain medications. NeoFarma Neurologia analyzes genes related to the response to medications used in neurology and psychiatry to add information to the evaluation of the team accompanying you.
About the test
a test focusing on neurology and psychiatry.
NeoFarma Neurologia analyzes a defined set of genes and interprets possible implications for the medicines included in the test. For other areas, the team can advise whether there is appropriate analysis prior to sample collection.
What DNA adds
Information for a more personalized conversation about the treatment.
The result may indicate points of attention regarding metabolism, response or adverse events based on the genes analyzed and the medications covered. The team integrates this data with the diagnosis, history and other clinical factors.
Possible differences in effect.
When there is sufficient evidence, the report may indicate that the chance of a response or an adverse event deserves attention.
One piece of information among many.
Age, kidney and liver function, other medications, diagnosis, previous response, and preferences remain key.
Safe use
The report is not an authorization to change treatment.
The assistant team assesses whether the finding is applicable now, whether it requires confirmation and how it relates to the clinical picture.
- 01
Stick to the prescribed schedule
Continue following current guidelines until you speak to the responsible professional. Stopping some medications abruptly can pose risks.
- 02
Take the complete list
Include continuous and occasional medications, doses, schedules, supplements, herbal medicines, allergies and previous reactions.
- 03
Confirm applicability
Not every medication has a validated pharmacogenetic recommendation, and an association may not justify a change for that person.
- 04
Observe the follow-up
Response, adverse events and control tests continue to be monitored even when genetics participates in the decision.
Test day
From the clinical question to the conversation about the result.
The usefulness of the test increases when the question, medications, and history are clear from the beginning.
Organize history
Record current and previous treatments, perceived response, unwanted effects and reason for each prescription.
Define the question
The professional checks whether there is relevant pharmacogenetic evidence for the medicines and the situation under analysis.
Collect and analyze
The sample follows the test instructions; the laboratory evaluates the genes and variants predicted in the contracted option.
Interpret the report
The team gathers genetics, symptoms, other medications, tests, and treatment goals before discussing any changes.
How to read the result
The report organizes what deserves clinical discussion.
The document describes the evidence found in the genes analyzed and its possible implications for the medicines considered. The assistant team decides with the person being treated whether the information is applicable.
- 01
Finding with guidance available
There may be a guideline-based recommendation for clinical discussion. It still needs to be related to the medication, the indication and the current health status.
- 02
No specific guidance
This does not mean the medicine will work or be safe. It just means that the test did not identify, in the genes analyzed, information that would change the pharmacogenetic interpretation for the medicines covered.
- 03
Uncertain information
A variant of uncertain significance (VUS) should not guide the choice, dose, suspension or change of medication. In all NeoGenomica tests, the reported VUS are included in the Infinity VUS follow-up.
Frequently asked questions
Questions about the test and the use of the results.
Does the test tell me which medication is best for me?
Not in isolation. It can add information for some medications, but the choice considers diagnosis, evidence of effectiveness, other diseases, interactions, previous response and preferences.
Can I reduce the dose when I receive the report?
Do not adjust on your own. Take the report to the responsible team, who will decide whether the information is applicable and whether any follow-up or changes are appropriate.
Does the result apply to all medications?
No. The test analyzes a defined set of genes and includes certain medications; the strength of recommendations varies. Please check the current version before sample collection.
Does the test predict all adverse effects?
No. Adverse events may also depend on the dose, interactions, other conditions and factors not yet known or not evaluated.
Stay informed
Take context, not just the report.
Learn about the technical product or prepare a list of questions for the consultation.
Next step
Find out about the test and ask any questions you may have before sample collection.
The team can explain what NeoFarma Neurologia analyzes and how to access the test. The result should be discussed with those following your treatment.
For patients and families
Information for each stage of the journey.
Start with the topic that comes closest to your question.
